Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose

Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine efficacy. We studied anti-SARS-CoV-2 Spike RBD IgG levels in 587 healthcare workers (2038 sera) who completed BNT162b2 vaccination. Average antibody titer 3 weeks after the first dose in COVID-19-naïve p...

Descripción completa

Detalles Bibliográficos
Autores principales: Đaković Rode, Oktavija, Bodulić, Kristian, Zember, Sanja, Cetinić Balent, Nataša, Novokmet, Anđa, Čulo, Marija, Rašić, Željka, Mikulić, Radojka, Markotić, Alemka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876023/
https://www.ncbi.nlm.nih.gov/pubmed/35214612
http://dx.doi.org/10.3390/vaccines10020153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876023/
https://www.ncbi.nlm.nih.gov/pubmed/35214612
http://dx.doi.org/10.3390/vaccines10020153

Ejemplares similares